WCG IRB

Highly Engaged Employees

WCG IRB, established in 1998, is a prominent provider of ethical review services for clinical research protocols and studies. Operating within the Business Services and Management Consulting sectors, the company leverages over 50 years of collective experience. Its AAHRPP-accredited boards comprise more than 200 members, ensuring high-quality oversight for research initiatives. WCG IRB focuses on maintaining the integrity and ethical standards of clinical trials, a critical component in advancing medical science and patient safety. The company's commitment to ethical review underpins its reputation in the research community.

Since 2000, WCG IRB has expanded its service offerings to include Institutional Biosafety Committee (IBC) administration and review, serving nearly 800 institutions. They have evaluated over 400 human gene transfer protocols, demonstrating specialized expertise in cutting-edge research areas. The company operates across 2 locations and employs between 500-1,000 individuals. WCG IRB generates an annual revenue of $22.1M, reflecting its significant market presence and operational scale. This financial performance supports its extensive infrastructure and dedicated team of professionals.

WCG IRB's extensive experience and robust board structure are key differentiators in the competitive landscape, which includes entities like Science 37 and Velocity Clinical Research. The company's dedication to ethical oversight and comprehensive review services positions it as a leader in its field. To understand the depth of expertise and leadership driving these operations, one can Meet WCG IRB's team. Their collective knowledge and commitment are instrumental in upholding the highest ethical standards in clinical research, ensuring participant safety and data integrity across all reviewed protocols.